RA Capital Management’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.5M | Hold |
9,714,392
| – | – | 1.56% | 17 |
|
|
2025
Q1 | $102M | Buy |
9,714,392
+3,333,248
| +52% | +$34.9M | 1.7% | 14 |
|
|
2024
Q4 | $150M | Hold |
6,381,144
| – | – | 2% | 12 |
|
|
2024
Q3 | $229M | Buy |
6,381,144
+331,940
| +5% | +$11.9M | 2.64% | 11 |
|
|
2024
Q2 | $213M | Buy |
6,049,204
+1,094,425
| +22% | +$38.6M | 2.82% | 10 |
|
|
2024
Q1 | $141M | Buy |
+4,954,779
| New | +$141M | 1.79% | 17 |
|
|
2022
Q3 | – | Sell |
-2,805,045
| Closed | -$19.3M | – | 86 |
|
|
2022
Q2 | $19.3M | Hold |
2,805,045
| – | – | 0.51% | 47 |
|
|
2022
Q1 | $27M | Hold |
2,805,045
| – | – | 0.59% | 49 |
|
|
2021
Q4 | $33.4M | Hold |
2,805,045
| – | – | 0.59% | 51 |
|
|
2021
Q3 | $45.6M | Hold |
2,805,045
| – | – | 0.63% | 41 |
|
|
2021
Q2 | $59M | Hold |
2,805,045
| – | – | 0.95% | 30 |
|
|
2021
Q1 | $43.6M | Hold |
2,805,045
| – | – | 0.66% | 43 |
|
|
2020
Q4 | $58.9M | Hold |
2,805,045
| – | – | 0.82% | 37 |
|
|
2020
Q3 | $56.6M | Buy |
+2,805,045
| New | +$56.6M | 1.04% | 30 |
|